AtriCure (ATRC) Tops Q1 EPS by 6c ; Offers Guidance
Get Alerts ATRC Hot Sheet
Price: $61.25 -1.97%
EPS Growth %: -300.0%
Financial Fact:
Interest expense: -530K
Today's EPS Names:
OPY, BNCC, ZVOI, More
EPS Growth %: -300.0%
Financial Fact:
Interest expense: -530K
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q1 EPS of $0.00, $0.06 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $141.2 million versus the consensus estimate of $139.54 million.
GUIDANCE:
AtriCure sees FY2026 EPS of $0.00-$0.04, versus the consensus of $0.14. AtriCure sees FY2026 revenue of $600-610 million, versus the consensus of $604.1 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
- Federal Realty Inv. Trust (FRT) Tops Q3 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share